New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
Placester Raises $15 Million in Series B Funding
-
IIX Completes $20 Million Financing With TriplePoint Capital
-
IIX Acquires Leading Interconnection Provider IX Reach
-
IfOnly, the marketplace for experiences, has partnered with the American Red Cross, Get Prepared California, Clear Channel, and iHeart Media to Offer Amazing Experiences for Good
-
ScoreStream scores $2 Million to win the local sports game
-
VytronUS, Inc. Attracts Industry Veteran John Pavlidis as New President and Chief Executive Officer
-
mNectar and Branch Metrics Partner to Bring Optimal User Experience to Mobile Ads
-
Fyusion Closes $13M Venture Round Led by NEA and UTEC
-
Sonatype Named to JMP Securities' Top 50 List of Hottest Privately Held Companies
-
SmartDrive Systems Raises $50 Million and Closes out Record Year
-
FusionOps Launches Application On Salesforce AppExchange
-
FusionOps Raises $12 Million To Accelerate Development and Global Expansion
-
FusionOps Announces Support For Oracle® Enterprise Business Suite
-
Vtesse, Inc. Forms Scientific Advisory Board
-
Form SC 13D/A AMICUS THERAPEUTICS INC Filed by: NEW ENTERPRISE ASSOCIATES 9 L P
-
Hancock Holding Company Announces Five-State Financial Literacy Partnership
-
Cohere Technologies Secures $35 Million in Series C Funding Led by Telstra
-
Form SC 13D CHAMPIONS ONCOLOGY, INC. Filed by: New Enterprise Associates 14, L.P.
-
Critical Outcome Technologies Establishes Advisory Board for the Clinical Development of COTI-2
-
Interleukin Genetics Reports Fourth Quarter and Year-End 2014 Financial Results
-
Form SC 13D/A TARGACEPT INC Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
hopOn Launches Social-First Travel Booking Service and Announces Seed Funding
-
Champions Oncology Announces $14 Million Capital Raise
-
PhaseBio Raises $40 Million Series C Financing Led by AstraZeneca
-
Cortendo Reports Results and Activities for the Fourth Quarter and Full Year 2014
-
TRACON Pharmaceuticals Reports 2014 Year-End Financial Results and Recent Corporate Highlights
-
TRACON Pharmaceuticals Reports 2014 Year-End Financial Results and Recent Corporate Highlights
-
Bypass Mobile Selected to Present at The Montgomery Summit
-
Enterprise Productivity Platform Do Integrates with Microsoft Office 365 and Raises $2M
-
Madison Logic Selected to Present at The Montgomery Summit
-
Scale Computing Selected to Present at The Montgomery Summit
-
Swiftype Raises $13M to Deliver Powerful Search
-
Branch Metrics Wins 2015 GSMA Mobile World Congress Startup Innovation Competition
-
Damballa Selected to Present at The Montgomery Summit
-
Form SC 13D Tracon Pharmaceuticals, Filed by: New Enterprise Associates 14, L.P.
-
Form SC 13G/A Millennial Media Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form SC 13G/A CVENT INC Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form SC 13G/A Groupon, Inc. Filed by: New Enterprise Associates 12, Limited Partnership
-
Form SC 13G NEVRO CORP Filed by: New Enterprise Associates 14, L.P.
-
Form SC 13G AEROHIVE NETWORKS, INC Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form SC 13G Care.com Inc Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form SC 13G OPOWER, INC. Filed by: New Enterprise Associates 12, Limited Partnership
-
Form SC 13G/A Tableau Software Inc Filed by: NEW ENTERPRISE ASSOCIATES 11 LP
-
Form SC 13G/A BOINGO WIRELESS INC Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
Form 4 Tracon Pharmaceuticals, For: Feb 04 Filed by: New Enterprise Associates 14, L.P.
-
Form SC 13G/A Workday, Inc. Filed by: New Enterprise Associates 12, Limited Partnership
-
Form SC 13G/A FUSION-IO, INC. Filed by: New Enterprise Associates 12, Limited Partnership
-
Form SC 13G/A CHANNELADVISOR CORP Filed by: New Enterprise Associates 12, Limited Partnership
-
TRACON Pharmaceuticals (TCON) Prices 3.6M Common IPO at $10/Share
-
TRACON Pharmaceuticals Announces Pricing of Initial Public Offering


